Is Illumina On The Verge of a Breakout?

Is Illumina On The Verge of a Breakout?

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

Everything We Know About BioCryst's New HAE Drug

Everything We Know About BioCryst's New HAE Drug

What You Need to Know About La Jolla's Shock-Treatment Drug

What You Need to Know About La Jolla's Shock-Treatment Drug

4 Biotech Stocks on the Move

4 Biotech Stocks on the Move

Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug

Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug

Biotech Movers: Cempra Flys High On Phase Three Results

Biotech Movers: Cempra Flys High On Phase Three Results

How to Dig Deep for Value in These Exuberant Markets

How to Dig Deep for Value in These Exuberant Markets

Biotech Movers: Shire Rises on Encouraging Angioedema Results

Biotech Movers: Shire Rises on Encouraging Angioedema Results